Global Clinical Microbiology Instruments and Reagents Market to Reach $5.8 Billion by 2026
28 sept. 2022 07h38 HE
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's...
Global Healthcare Analytical Testing Services Market Report 2022: Growing Demand for Biosimilars Driving Sector
22 sept. 2022 04h13 HE
|
Research and Markets
Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report by Type (Medical Device, Pharmaceutical), by Region (APAC,...
India Rapid IVD Kits Market Outlook 2022-2027 - A Highly Fragmented Market with SD Biosensor as the Market Leader
20 sept. 2022 07h48 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "India Rapid IVD Kits Market Outlook to FY'2027F" report has been added to ResearchAndMarkets.com's offering. India Rapid IVD Kits industry (ex....
Brain Monitoring Global Market Report 2022: Implementation of AI Presents Opportunities for Growth
20 sept. 2022 05h43 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Brain Monitoring Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global brain monitoring market is expected...
Pardes Biosciences Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directors
14 sept. 2022 08h00 HE
|
Pardes Biosciences, Inc
CARLSBAD, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (Nasdaq: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone, novel oral...
Pardes Biosciences Announces Commencement of Phase 2 Trial Evaluating PBI-0451 for the Treatment of SARS-CoV-2 Infections
13 sept. 2022 08h00 HE
|
Pardes Biosciences, Inc
Phase 2 trial expected to enroll 210 patients at approximately 75 sites to evaluate antiviral activity, safety, and efficacy of PBI-0451 versus placebo Interim data from Phase 2 anticipated in Q1...
Winsor Learning Releases Free Professional Development Resource for Administrators and Teachers of Reading in Response to Steep Declines in National Reading Scores
12 sept. 2022 16h00 HE
|
Winsor Learning
MINNEAPOLIS, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Today, in the wake of devastating recent news about the nation's reading test scores, Minnesota-based Winsor Learning, the nation's leading expert and...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für Auffrischungsimpfung mit an Omikron BA.4/BA.5-angepassten bivalenten COVID-19-Impfstoff in der Europäischen Union
12 sept. 2022 11h20 HE
|
BioNTech SE
CHMP-Empfehlung stützt sich auf vorteilhafte Ergebnisse der an Omikron-angepassten Impfstoffe Der an Omikron BA.4/BA.5-angepasste bivalente COVID-19-Auffrischungsimpfstoff enthält 15 µg mRNA, die für...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
12 sept. 2022 11h20 HE
|
BioNTech SE
CHMP recommendation based on favorable data from Omicron-adapted vaccinesThe Omicron BA.4/BA.5 bivalent COVID-19 booster vaccine combines 15-µg of mRNA encoding the wild-type spike protein of...
Global HPV Testing and PAP Test Market 2022: Continuous Clinical Trials, Developments, and Product Launches Propel Sector
08 sept. 2022 07h43 HE
|
Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...